Cheat sheet

ANCC CV-BC Cheat Sheet

Quick Facts

Exam
ANCC CV-BC
Credential
Cardiac-Vascular Nurse, Board Certified
Questions
150 total; 125 scored
Time
3 hours
Pass
350 scaled of 500
Pass rate
67% first-time (2025)
Fee
$395; $295 ANA member
Valid
5 years
Retest
60 days; 3 yearly
Renewal
75 CE hours
Blueprint
Dec 5, 2024

Infarct Lead Groups

II, III, aVF = inferior = right coronary

V1-V2: septalV3-V4: anteriorI, aVL, V5-V6: lateralV7-V9: posterior

STEMI vs NSTEMI

STEMI

  • Complete occlusion
  • Persistent ST elevation
  • Immediate reperfusion

NSTEMI

  • Partial occlusion
  • ST depression or inversion
  • Troponin positive

Elevation means immediate reperfusion

Chest Pain Triage

  1. New chest discomfort12-lead within 10 minutes(First action)
  2. ST elevation presentActivate STEMI team(Start clock)
  3. Depression, troponin positiveNSTEMI pathway(Risk stratify)
  4. Normal ECG and troponinSerial troponin, monitor(0/1-hour protocol)
  5. Inferior ST elevationAdd right-sided leads(Check V4R)
  6. Tearing pain, unequal pulsesSuspect aortic dissection(No fibrinolytics)
  7. Took PDE5 inhibitorWithhold nitroglycerin(24 to 48 hours)

Hemodynamic Normals

Cardiac output
4-8 L/min
Cardiac index
2.5-4.0 L/min/m2Under 2.2 hypoperfusion
CVP
2-8 mm HgRight preload
PAOP / PCWP
6-12 mm HgOver 18 congestion
PA pressure
15-30/8-15 mm Hg
MAP
70-105 mm HgShock target 65
SVR
800-1200 dynes-s/cm5
Stroke volume index
33-47 mL/beat/m2

Acute Limb Ischemia

Pain, Pallor, Pulseless, Paresthesia, Paralysis, Poikilothermia

Pulseless: surgical emergencyParalysis: late signTime is limb

Stable vs Unstable Angina

Stable

  • Predictable exertion trigger
  • Relieved by rest
  • Normal troponin

Unstable

  • New or rest pain
  • Not relieved by rest
  • Normal troponin, still ACS

Pattern change means ACS

Infarct Leads

V1-V2
Septal; LAD
V3-V4
Anterior; LAD
I, aVL, V5-V6
Lateral; circumflex
II, III, aVF
Inferior; right coronary
V7-V9
Posterior; circumflex or RCA
V4R
Right ventricle; proximal RCAPreload dependent
aVR elevation
Left main or multivessel

Right vs Left Heart Failure

Right sided

  • JVD, hepatomegaly
  • Ascites, dependent edema
  • Hepatojugular reflux

Left sided

  • Crackles, orthopnea
  • Exertional dyspnea
  • Paroxysmal nocturnal dyspnea

Systemic vs pulmonary congestion

STEMI ECG Criteria

Most leads
1 mm, two contiguous
V2-V3, men 40+
2 mm elevation
V2-V3, men under 40
2.5 mm elevation
V2-V3, women
1.5 mm elevation
Measured at
J point
Reciprocal change
Depression in opposite wall
New LBBB
Not automatic STEMI; apply Sgarbossa

S3 vs S4

S3

  • Early diastole
  • Volume overload
  • Decompensated heart failure

S4

  • Late diastole
  • Stiff ventricle
  • Absent in atrial fibrillation

Volume vs stiffness

Heart Sounds

S3
Early diastole; volume overload
S4
Stiff ventricle; absent in AF
Aortic stenosis
Systolic; radiates to carotids
Aortic regurgitation
Diastolic; wide pulse pressure
Mitral regurgitation
Holosystolic; radiates to axilla
Mitral stenosis
Diastolic rumble; opening snap
Mitral valve prolapse
Mid-systolic click
Pericardial rub
Scratchy; better leaning forward
Pulsus paradoxus
Tamponade; drop over 10

Cardiac Labs

hs-troponin
Injury; needs rise or fall0/1-hour protocol
BNP
Wall stress; rules out HF
NT-proBNP
Usable on sacubitril/valsartan
D-dimer
Sensitive, not specific
INR
Warfarin effect
aPTT
Unfractionated heparin monitoring
Anti-Xa
Heparin or LMWH level
Potassium
MRA and ACE inhibitor safety
Creatinine clearance
DOAC dosing

ABI Values

Calculation
Ankle divided by brachial
1.00-1.40
Normal
0.91-0.99
Borderline
0.90 or less
Peripheral artery disease
0.40 or less
Severe ischemia; rest pain
Above 1.40
Noncompressible; use toe pressure

HFrEF Four Pillars

ARNI + beta-blocker + MRA + SGLT2 inhibitor

ARNI: sacubitril/valsartanBeta-blocker: carvedilolMRA: spironolactoneSGLT2i: dapagliflozin

HFrEF vs HFpEF

HFrEF

  • LVEF 40% or less
  • Dilated, weak pump
  • Four-pillar GDMT

HFpEF

  • LVEF 50% or more
  • Stiff, poor filling
  • SGLT2i, diuretic, comorbidities

Weak pump vs stiff

STEMI Reperfusion Pathway

  1. At PCI-capable hospitalPrimary PCI, 90 minutes
  2. Transfer under 120 minutesTransfer for primary PCI
  3. PCI beyond 120 minutesFibrinolysis, 30 minutes
  4. Onset beyond 12 hoursPCI, not fibrinolysis
  5. Prior intracranial hemorrhageFibrinolysis contraindicated(Absolute)
  6. Cardiogenic shockImmediate invasive strategy
  7. After reperfusionDAPT, statin, beta-blocker

HFrEF Four Pillars

ARNI
Sacubitril/valsartan preferred
Beta-blocker
Carvedilol, metoprolol succinate, bisoprolol
MRA
Spironolactone or eplerenone
SGLT2 inhibitor
Dapagliflozin or empagliflozin
Loop diuretic
Congestion; no mortality benefit
ARNI washout
36 hours off ACE inhibitor
HFrEF
LVEF 40% or less
HFmrEF
LVEF 41-49%
HFpEF
LVEF 50% or more

CHA2DS2-VASc Score

CHF, HTN, Age, Diabetes, Stroke, Vascular, Sex

Age 75 or older: 2Stroke or TIA: 2All others: 1 pointTreat 2 men, 3 women

Warfarin vs DOAC

Warfarin

  • Routine INR monitoring
  • Vitamin K interactions
  • Vitamin K, 4F-PCC

DOAC

  • No routine monitoring
  • Renal and weight dosing
  • Idarucizumab, andexanet alfa

Monitor INR vs renal dosing

Choosing HF GDMT

  1. LVEF 40% or lessStart four pillars
  2. Already on ACE inhibitorSwitch to ARNI(36-hour washout)
  3. ARNI not feasibleACE inhibitor or ARB
  4. Potassium under 5.0Add MRA(eGFR above 30)
  5. On other pillarsAdd SGLT2 inhibitor(Diabetes not required)
  6. Volume overloadedAdd loop diuretic(Symptoms only)
  7. LVEF 35% after monthsRefer for ICD(40 days post-MI)
  8. LBBB, QRS 150 msAdd CRT

ACS Time Targets

First ECG
Within 10 minutes
Primary PCI
90 minutes from contact
Transfer for PCI
120 minutes from contact
Fibrinolysis
Door-to-needle 30 minutes
Fibrinolysis window
Within 12 hours onset
Troponin protocol
0/1 or 0/2 hours
Access preference
Radial over femoral
High-intensity statin
Started during hospitalization

Cardioversion vs Defibrillation

Synchronized

  • Pulse present
  • AF, SVT, monomorphic VT
  • Timed to R wave

Unsynchronized

  • Pulseless patient
  • VF, pulseless VT
  • Polymorphic VT

Pulse means synchronize

AF Stroke Prevention

  1. New atrial fibrillationScore CHA2DS2-VASc
  2. Score 2 men, 3 womenAnticoagulate(Risk 2% yearly)
  3. No mechanical valveDOAC over warfarin
  4. Mechanical valve, rheumatic stenosisWarfarin only
  5. AF beyond 48 hoursTEE or 3 weeks
  6. Unstable with rapid rateSynchronized cardioversion
  7. Anticoagulation contraindicatedConsider appendage occlusion

Antithrombotics

Aspirin
Irreversible COX-1 blockade
Clopidogrel
P2Y12 prodrug; CYP2C19
Ticagrelor
Reversible P2Y12; dyspnea
Prasugrel
Avoid after stroke or TIA
Unfractionated heparin
aPTT titrated; reversible
Enoxaparin
Renally dosed LMWH
Bivalirudin
Direct thrombin inhibitor
Argatroban
Anticoagulant of choice, HIT
DAPT duration
At least 12 monthsTicagrelor alone after month

Radial vs Femoral Access

Radial

  • Compression band
  • Early ambulation
  • Check hand perfusion

Femoral

  • Supine bed rest
  • Leg kept straight
  • Watch retroperitoneal bleed

Radial bleeds less

Anticoagulation Targets

AF or VTE
INR 2.0-3.0
Bioprosthetic valve
INR 2.0-3.0
Mechanical mitral valve
INR 2.5-3.5
Dabigatran reversal
Idarucizumab
Factor Xa reversal
Andexanet alfa
Warfarin reversal
Vitamin K, 4F-PCC
Heparin reversal
Protamine sulfate
DOAC monitoring
Renal function, not INR

Procedures and Devices

PCI
Stent the culprit lesion
CABG
Bypass with graft conduits
TAVR
Transcatheter aortic valve replacement
TEER
Edge-to-edge mitral repair
IABP
Inflate diastole, deflate systole
LVAD
Continuous flow; Doppler MAP
ECMO
Temporary cardiopulmonary support
ICD
LVEF 35% or less40 days post-MI
CRT
LBBB with QRS 150 ms
Severe aortic stenosis
Mean gradient 40 mm Hg
Severe mitral stenosis
Valve area 1.5 cm2

Cath Access Care

Radial access
Band with patent hemostasis
Radial checks
Color, warmth, sensation, refill
Femoral access
Supine, leg straight, flat
Hematoma
Hold pressure; mark border
Pseudoaneurysm
Pulsatile mass; new bruit
Retroperitoneal bleed
Back or flank pain
Contrast nephropathy
Hydrate; trend creatinine

Tamponade Beck Triad

Hypotension + JVD + muffled heart sounds

Pulsus paradoxus over 10Narrow pulse pressurePericardiocentesis treats

Hypertensive Urgency vs Emergency

Urgency

  • No target organ damage
  • Oral agents
  • Gradual outpatient lowering

Emergency

  • Target organ damage
  • IV titratable agent
  • Lower 25% first hour

Organ damage decides

Hemodynamic Profiles

  1. Warm and dryCompensated; continue GDMT
  2. Warm and wetIV diuretic, vasodilator
  3. Cold and wetInotrope plus diuretic
  4. Cold and dryCautious fluid, then inotrope
  5. Index under 2.2, hypotensiveCardiogenic shock pathway
  6. High CVP, clear lungsSuspect right ventricular infarct

Drug Interactions

Amiodarone + digoxin
Halve the digoxin dose
Amiodarone + warfarin
INR climbs; reduce dose
Nitrate + PDE5 inhibitor
Profound refractory hypotension
Sildenafil, vardenafil
Hold nitrates 24 hours
Tadalafil
Hold nitrates 48 hours
ACE inhibitor to ARNI
36-hour washout
MRA + ACE inhibitor
Hyperkalemia; recheck potassium
Warfarin + vitamin K
Consistency, not avoidance
Statin + gemfibrozil
Rhabdomyolysis risk

Adverse Events

HIT
Platelets fall 50%; thrombosisDay 5-10
ACE inhibitor cough
Switch to ARB
ARNI angioedema
Stop drug; secure airway
Hyperkalemia
Stop MRA above 5.5
Digoxin toxicity
Nausea, halos, arrhythmia
Statin myopathy
Muscle pain; check CK
Amiodarone toxicity
Thyroid, liver, lung, eye
IV amiodarone
In-line filter; central preferred
Warfarin bleeding
Hold; vitamin K

Emergency Thresholds

Hypertensive emergency
Lower 25% first hour
Aortic dissection
Systolic under 120 mm Hg
Cardiogenic shock
Systolic under 90; hypoperfusion
Shock vasopressor
Norepinephrine first line
Stroke thrombolysis
Within 4.5 hoursDoor-to-needle 60
Thrombectomy window
Up to 24 hours
Post-arrest temperature
32-37.5 degrees CelsiusHold 36 hours
Cardiac tamponade
Beck triad; pulsus paradoxus
High-risk PE
Hypotension; consider thrombolysis

Smoking Cessation 5 A's

Ask, Advise, Assess, Assist, Arrange

Ask at every visitAssist: counseling plus drugArrange follow-up

ACC/AHA Stage vs NYHA Class

ACC/AHA stage

  • Structural progression
  • Stages A through D
  • Never moves backward

NYHA class

  • Functional symptoms
  • Class I through IV
  • Can improve or worsen

Structure vs symptoms

Education Barrier Picker

  1. Low health literacyTeach-back, plain language
  2. Vision or dexterity limitsPill organizer, large print
  3. Limited English proficiencyQualified medical interpreter
  4. Cost barrierAssistance program referral
  5. Recent MI or PCIRefer cardiac rehabilitation
  6. Starting warfarinAnticoagulation clinic referral

BP Categories

Normal
Under 120/80 mm Hg
Elevated
120-129 systolic, under 80
Stage 1
130-139 or 80-89
Stage 2
140 or 90 higher
Crisis
Above 180/120 mm Hg
Treatment goal
Under 130/80 mm Hg
Risk calculator
PREVENT equations

Lifestyle Targets

Aerobic activity
150 minutes weekly, moderate
Vigorous activity
75 minutes weekly
Strength training
Two or more days
Sodium limit
Under 2,300 mg dailyOptimal 1,500 mg
High-intensity statin
Lowers LDL 50% or more
Post-ACS LDL
Add nonstatin at 70
Smoking cessation
Counseling plus pharmacotherapy
Nonmodifiable risks
Age, sex, race, family

Home Monitoring

Daily weight
Same scale, after voiding
Report weight gain
2-3 pounds overnight, 5 weekly
BP technique
Rest 5 minutes, bare arm
BP readings
Two, one minute apart
Nitroglycerin rule
No relief 5 minutes, 911
Symptom action plan
Green, yellow, red zones
Teach-back
Patient explains in own words

Community Resources

Cardiac rehab
Up to 36 supervised sessions
Rehab referral
MI, PCI, CABG, valve
HF rehab coverage
LVEF 35% or less
Anticoagulation clinic
Dosing; time in range
Home INR testing
Fingerstick point-of-care meter
Remote CIED check
Lead, battery, fluid trends
HF follow-up
Visit within 7 days

Common Traps

Injury vs infarction

Troponin shows injury MI needs ischemic evidence

S3 vs S4

S3 is volume S4 is stiffness

Urgency vs emergency

Urgency spares organs Emergency damages organs

Sync vs defibrillate

Pulse means synchronize Pulseless means defibrillate

Rate vs rhythm control

Rate slows ventricles Rhythm restores sinus

Nitrates in RV infarct

RV is preload dependent Nitrates drop pressure abruptly

Vitamin K teaching

Consistency, not avoidance Report every diet change

BNP on ARNI

Sacubitril raises BNP NT-proBNP stays usable

Stage vs class

HF stage never reverses NYHA class can improve

Scored vs pretest

125 questions scored 25 pretest not scored

Last Minute

  1. 1.Planning 35% is largest domain
  2. 2.Education 25%; Assessment 22%
  3. 3.Evaluation and Modification is 18%
  4. 4.150 questions; only 125 scored
  5. 5.Pass = 350 scaled of 500
  6. 6.Primary PCI within 90 minutes
  7. 7.Fibrinolysis needle within 30 minutes
  8. 8.HFrEF pillars: ARNI, BB, MRA, SGLT2i
  9. 9.ACE to ARNI = 36-hour washout
  10. 10.Anticoagulate CHA2DS2-VASc 2 men, 3 women
  11. 11.INR 2-3; mechanical mitral 2.5-3.5
  12. 12.ABI 0.90 or less = PAD
  13. 13.BP treatment goal under 130/80
  14. 14.Report 2-3 pound overnight gain
  15. 15.Nitroglycerin: no relief 5 minutes, 911
  16. 16.Cardiac rehab: up to 36 sessions
  17. 17.Pulse = synchronize; pulseless = defibrillate
  18. 18.Hold nitrates after PDE5 inhibitors
Same family resources

Explore More ANCC Nursing Certifications

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.